Viewing Study NCT04711161


Ignite Creation Date: 2025-12-24 @ 12:20 PM
Ignite Modification Date: 2025-12-24 @ 12:20 PM
Study NCT ID: NCT04711161
Status: SUSPENDED
Last Update Posted: 2024-01-23
First Post: 2020-12-24
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers.
Sponsor: Green3Bio, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module